TableĀ 1

Origin of different tumour patient-derived cell lines and the potential treatment given to patients before sampling

Patient numberPatient-derived cell line nameOriginTreatment before sampling
41CTC41BloodNone
44CTC44BloodNone
CPP44Primary tumourNone
45CTC45BloodNone
CPP45Liver metastasisNone
24CPP24Primary tumourBevacizumab Cetuximab FOLFIRI
25CPP25Primary tumourCapecitabine
19CPP19Liver metastasisBevacizumab FOLFIRI
30CPP30Liver metastasisBevacizumab FOLFOX4
FOLFIRI Xelox
  • CTC, circulating tumour cell.